Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Christine Petereit

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 14, 2012
Optimizing solubility: kinetic versus thermodynamic solubility temptations and risksChristoph Saal, Anna Christine Petereit
Journal of Pharmaceutical Sciences|October 23, 2010
Characterization of a new solvate of risedronateJürgen Brüning, Anna Christine Petereit, Edith Alig, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 25, 2010
Prediction of blood-brain barrier penetration of poorly soluble drug candidates using surface activity profilingAnna Christine Petereit, Kelly Swinney, Jurgen Mensch, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 14, 2012
Optimizing solubility: kinetic versus thermodynamic solubility temptations and risksChristoph Saal, Anna Christine Petereit
Journal of Pharmaceutical Sciences|October 23, 2010
Characterization of a new solvate of risedronateJürgen Brüning, Anna Christine Petereit, Edith Alig, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 25, 2010
Prediction of blood-brain barrier penetration of poorly soluble drug candidates using surface activity profilingAnna Christine Petereit, Kelly Swinney, Jurgen Mensch, et al.
Pageof 1